| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T P Zahn, D Pickar, R J Haie. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophrenia research. vol 13. issue 2. 1995-01-09. PMID:7986770. |
effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. |
1995-01-09 |
2023-08-12 |
human |
| S A Cohen, M T Underwoo. The use of clozapine in a mentally retarded and aggressive population. The Journal of clinical psychiatry. vol 55. issue 10. 1994-12-23. PMID:7961521. |
clozapine has proven efficacy in the management of treatment-resistant schizophrenia. |
1994-12-23 |
2023-08-12 |
Not clear |
| J A Lieberman, A Z Safferman, S Pollack, S Szymanski, C Johns, A Howard, M Kronig, P Bookstein, J M Kan. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. The American journal of psychiatry. vol 151. issue 12. 1994-12-20. PMID:7977880. |
clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. |
1994-12-20 |
2023-08-12 |
Not clear |
| R G Stern, R S Kahn, M Davidson, R M Nora, K L Davi. Early response to clozapine in schizophrenia. The American journal of psychiatry. vol 151. issue 12. 1994-12-20. PMID:7977893. |
early response to clozapine in schizophrenia. |
1994-12-20 |
2023-08-12 |
Not clear |
| J Welch, T Manschreck, D Redmon. Clozapine-induced seizures and EEG changes. The Journal of neuropsychiatry and clinical neurosciences. vol 6. issue 3. 1994-12-05. PMID:7950347. |
clozapine, an atypical antipsychotic drug, is widely used in refractory schizophrenia. |
1994-12-05 |
2023-08-12 |
Not clear |
| Y Levkowitz, Y Kronnenberg, N Kaysar, H Harari, B Gaon. [Clozapine in adolescence onset schizophrenia]. Harefuah. vol 127. issue 1-2. 1994-12-02. PMID:7959380. |
[clozapine in adolescence onset schizophrenia]. |
1994-12-02 |
2023-08-12 |
Not clear |
| Y Levkowitz, Y Kronnenberg, N Kaysar, H Harari, B Gaon. [Clozapine in adolescence onset schizophrenia]. Harefuah. vol 127. issue 1-2. 1994-12-02. PMID:7959380. |
clozapine is an atypical neuroleptic agent given when schizophrenia is resistant to other neuroleptic drugs. |
1994-12-02 |
2023-08-12 |
Not clear |
| Y Levkowitz, Y Kronnenberg, N Kaysar, H Harari, B Gaon. [Clozapine in adolescence onset schizophrenia]. Harefuah. vol 127. issue 1-2. 1994-12-02. PMID:7959380. |
in our opinion, clozapine should be considered when severe schizophrenia in adolescents is refractory to other neuroleptic agents, provided the wbc count is monitored. |
1994-12-02 |
2023-08-12 |
Not clear |
| D Pickar, R R Owen, R E Litman, J K Hsiao, T P S. Predictors of clozapine response in schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7525541. |
predictors of clozapine response in schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |
| D Pickar, R R Owen, R E Litman, J K Hsiao, T P S. Predictors of clozapine response in schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7525541. |
the introduction of the atypical neuroleptic, clozapine, has had widespread influence not only on the treatment of the seriously mentally ill patient, but also on new drug development and on hypotheses of the pathophysiology of schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |
| D Pickar, R R Owen, R E Litman, J K Hsiao, T P S. Predictors of clozapine response in schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7525541. |
further, our data suggest that clozapine should not be reserved for the most chronically ill patients, but rather be utilized in patients with less chronic courses of schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |
| T E Goldberg, D R Weinberge. The effects of clozapine on neurocognition: an overview. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7525543. |
clozapine has proved effective in alleviating a wide range of psychiatric symptoms in schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |
| C A Tamminga, G K Thaker, M Moran, T Kakigi, X M Ga. Clozapine in tardive dyskinesia: observations from human and animal model studies. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961550. |
clozapine has long been considered a useful treatment in patients who have schizophrenia with the neuroleptic-induced delayed-onset side effect tardive dyskinesia. |
1994-11-28 |
2023-08-12 |
human |
| P Buckley, P A Thompson, L Way, H Y Meltze. Substance abuse and clozapine treatment. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961553. |
among 118 patients with dsm-iii-r diagnoses of schizophrenia or schizoaffective disorder who received treatment with clozapine, 29 patients had an antecedent or current history of substance abuse. |
1994-11-28 |
2023-08-12 |
Not clear |
| J A Lieberman, J M Kane, A Z Safferman, S Pollack, A Howard, S Szymanski, S J Masiar, M H Kronig, T Cooper, H Novacenk. Predictors of response to clozapine. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961556. |
associations were found between therapeutic response and the following variables: male gender, paranoid schizophrenia subtype diagnosis, older age at onset of illness, shorter duration of illness, higher levels of pretreatment acute eps, low pretreatment csf hva/5-hiaa, greater decrease in prolactin (prl) and increase in growth hormone (gh) response to apomorphine stimulation pretreatment and greater inhibition by clozapine treatment of prl and gh response to apomorphine, and plasma clozapine levels above 350 ng/ml. |
1994-11-28 |
2023-08-12 |
Not clear |
| S G Potkin, R Bera, B Gulasekaram, J Costa, S Hayes, Y Jin, G Richmond, D Carreon, K Sitanggan, B Gerbe. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961557. |
plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |
| D S Umbricht, S Pollack, J M Kan. Clozapine and weight gain. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961563. |
to investigate the association of clozapine treatment and weight gain, we studied short- and long-term weight gain, correlation of weight gain with treatment response, and risk factors for weight gain in 82 patients with chronic schizophrenia who received clozapine treatment for up to 90 months. |
1994-11-28 |
2023-08-12 |
Not clear |
| J W Olney, N B Farbe. Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961572. |
we have found that the nan reaction in rats can be prevented by specific drugs that prevent nap in humans and by certain antipsychotic agents, including clozapine, that ameliorate symptoms in schizophrenia. |
1994-11-28 |
2023-08-12 |
rat |
| J W Olney, N B Farbe. Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961572. |
by studying mechanisms by which clozapine prevents the nan reaction in rats, we hope to gain insight into mechanisms by which clozapine or other atypical antipsychotics ameliorate symptoms in schizophrenia. |
1994-11-28 |
2023-08-12 |
rat |
| R M Bilder, H Wu, M H Chakos, B Bogerts, S Pollack, J Aronowitz, M Ashtari, G Degreef, J M Kane, J A Lieberma. Cerebral morphometry and clozapine treatment in schizophrenia. The Journal of clinical psychiatry. vol 55 Suppl B. 1994-11-28. PMID:7961574. |
cerebral morphometry and clozapine treatment in schizophrenia. |
1994-11-28 |
2023-08-12 |
Not clear |